These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34630912)

  • 1. Alcoholic liver disease: Current insights into cellular mechanisms.
    Petagine L; Zariwala MG; Patel VB
    World J Biol Chem; 2021 Sep; 12(5):87-103. PubMed ID: 34630912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the gut barrier for the treatment of alcoholic liver disease.
    Zhou Z; Zhong W
    Liver Res; 2017 Dec; 1(4):197-207. PubMed ID: 30034913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
    Kim MS; Ong M; Qu X
    World J Gastroenterol; 2016 Jan; 22(1):8-23. PubMed ID: 26755857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholic liver disease: A current molecular and clinical perspective.
    Ohashi K; Pimienta M; Seki E
    Liver Res; 2018 Dec; 2(4):161-172. PubMed ID: 31214376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.
    Li S; Tan HY; Wang N; Feng Y; Wang X; Feng Y
    Front Immunol; 2019; 10():1328. PubMed ID: 31244862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress.
    Marí M; Morales A; Colell A; García-Ruiz C; Fernández-Checa JC
    Redox Biol; 2014; 3():100-8. PubMed ID: 25453982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approaches for Studying Alcoholic Liver Disease.
    Xu J; Liu X; Gao B; Karin M; Tsukamoto H; Brenner D; Kisseleva T
    Curr Pathobiol Rep; 2014 Dec; 2(4):171-183. PubMed ID: 26594598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence.
    Ghorbani Z; Hajizadeh M; Hekmatdoost A
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):348-60. PubMed ID: 27498574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease.
    Martinez-Castillo M; Altamirano-Mendoza I; Sánchez-Valle S; García-Islas L; Sánchez-Barragán M; Hernández-Santillán M; Hernández-Barragán A; Pérez-Hernández JL; Higuera-de la Tijera F; Gutierrez-Reyes G
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(2):136-154. PubMed ID: 36973122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.
    Neuman MG; Seitz HK; French SW; Malnick S; Tsukamoto H; Cohen LB; Hoffman P; Tabakoff B; Fasullo M; Nagy LE; Tuma PL; Schnabl B; Mueller S; Groebner JL; Barbara FA; Yue J; Nikko A; Alejandro M; Brittany T; Edward V; Harrall K; Saba L; Mihai O
    Biomedicines; 2020 Mar; 8(3):. PubMed ID: 32197424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Hong M; Han DH; Hong J; Kim DJ; Suk KT
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol or Gut Microbiota: Who Is the Guilty?
    Meroni M; Longo M; Dongiovanni P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer.
    Méndez-Sánchez N; Valencia-Rodriguez A; Vera-Barajas A; Abenavoli L; Scarpellini E; Ponciano-Rodriguez G; Wang DQ
    Hepatoma Res; 2020; 6():. PubMed ID: 32582865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in alcoholic and nonalcoholic steatohepatitis.
    Feldstein AE; Gores GJ
    Front Biosci; 2005 Sep; 10():3093-9. PubMed ID: 15970563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
    Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
    Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.